Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections.

Yeon Ju La Hye Rim Kim Dong Hyun Oh Jin Young Ahn Yong Chan Kim

Published in: Yonsei medical journal (2022)

Definitive therapy with beta-lactams in patients with MSSA BSI was associated with lower 28-day mortality compared to definitive therapy with glycopeptides.

Keyphrases

staphylococcus aureus
locally advanced
cardiovascular events
methicillin resistant staphylococcus aureus
biofilm formation
stem cells
squamous cell carcinoma
escherichia coli
coronary artery disease
radiation therapy
cystic fibrosis
cell therapy
bone marrow
mesenchymal stem cells
pseudomonas aeruginosa